Circulating endothelial progenitor cells: a new approach to anti-aging medicine?

Through this study, it was shown that Stem-Kine supplementation administered over a 2 week period (2 pills a day, twice daily) resulted in an increase in circulating endothelial progenitor cells expressing VEGFR2 and CD34, which was maintained for a period of at least 14 days (see graph).

The focus of this study was to demonstrate the importance of circulating endothelial progenitor cells and their application to the process of aging. EPCs provide a continual source of replenishment for the blood vessels, which is extremely important in damaged or senescent blood vessels. In the study, factors regarding EPCs and their migration, mobilization, as well as function, are discussed.

Stem-Kine Supplementation Augments Circulating EPC.

Y-Axis represents percentage double positive cells from cells (double-staining for VEGFR2 and CD34).

Not only are EPCs an important consideration for the process of aging, but there is a whole host of other potential applications regarding the importance of increasing circulating EPCs, see The Science.

Read the full article

Reference: Mikirova et al. Circulating endothelial progenitor cells: a new approach to anti-aging medicine? Journal of Translational Medicine 2009, 7:106.